Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 October 2022 | Story Dr Cinde Greyling | Photo Iflair Photography
UFS Business school
The UFS Business School.

The University of the Free State Business School (UFSBS) was established in the late 1990s and is fully accredited by the Council on Higher Education (CHE) and the Central and East European Management  Development Association (CEEMAN). Since its inception, the school has operated as a boutique business school focusing on personal attention to adult learners.

Late 2021, the UFSBS appointed a new Director, Dr Udesh Pillay. In conjunction with the change in leadership, the UFSBS is embarking on a new strategic journey, while maintaining the focus on its core business – in other words, its official academic offerings. The strategic journey of the UFSBS has been underway for the past year, and significant time has been allocated to the recurriculation of programme offerings; decolonisation of the academic agenda; and orientating the UFSBS so that it makes a larger practical contribution to the SME sector locally and nationally, especially in relation to business continuity and resilience in the wake of unforeseen externalities.  These developments will ensure that the UFSBS remains a premier academic institution and contributes to the success of South Africa and its people. It also ensures that the twin principles of academic excellence and social justice become mutually reinforcing.

The UFSBS’s strategic direction for the next five years aligns neatly with the Vision 130. By 2034 – when the university commemorates its 130th anniversary – the UFS wants to be recognised and acknowledged by peers and society as a top-tier university in South Africa. Similarly, the UFSBS has aspirations to become a top-ten business school in SA over the next five years.

Given the history of South Africa, it is of utmost importance to empower people to add value, particularly in the field of business and management leadership. The UFSBS will contribute to building an ecosystem of entrepreneurialism, with the more traditional academic programmes based upon the conventional practices of teaching and learning, research, and mentorship to be supplemented by ‘opportunity-driven initiatives’, such as executive education, consulting support, coaching, incubation services, and the commercialisation of intellectual property.

Globally, the Fourth Industrial Revolution (4IR) has catalysed processes of digital transformation in business, to which the UFSBS will align to ensure that students are equipped with the relevant knowledge and skills in a fast-changing, technology-enabled world. With the support of the Centre for Business Dynamics (CBD) housed in the UFSBS; the establishment of the Small Business Academy (SBA) in early 2024 in the UFSBS; the soon-to-be-established High-Growth Business Incubator (in collaboration with the NAS faculty); and with the process of strengthening relationships with the Paradys Experimental Farm gaining traction, a differentiated medium has been created to nurture responsible,  ethical, and socially conscious business leaders. The foundation then – to create the next generation of business leaders and entrepreneurs to become agents of change and value co-creators for business and society – will thus have begun.

The UFSBS will align to ensure that students are equipped with relevant knowledge and skills in a fast-changing, technology-enabled world. – Dr Udesh Pillay.
The slogan, ‘BE WORTH MORE’, embodies what the UFSBS strives for, and is consistent with new developments in global discourses, which are rethinking and transforming many of the traditional dogmas that have informed the mandates of business schools. 

As a critical bridge between academia and business, the UFSBS is uniquely poised to reimagine a better and intelligent future that is data-informed, collaborative, innovative, and inclusive.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept